Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Earnings Preview: Aytu BioPharma
Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here’s what investors…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Telesis Bio (NASDAQ:TBIO) shares increased by 32.5% to $0.53 during Wednesday’s after-market session. The company’s market cap…
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Heron Therapeutics (NASDAQ:HRTX) stock moved upwards by 63.0% to $0.88 during Wednesday’s regular session. As of 12:31…
Earnings Scheduled For November 14, 2023
Companies Reporting Before The Bell
• CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
Aytu BioPharma’s Earnings: A Preview
Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here’s what investors…
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move.
High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.
Aytu BioPharma Announces Approval Of The Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to Contract ManufacturerUpon Completion of Manufacturing Transfer of Adzenys XR-ODT and Cotempla
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Bionomics (NASDAQ:BNOX) stock increased by 261.4% to $3.56 during Thursday’s regular session. As of 13:30 EST, Bionomics’s…